Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Mats Wahlstrom

Director at TriSalus Life Sciences, Inc. (TLSI)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return+73.9%
vs. S&P 500+69.1%
Beat the market100%
Paper profit on buys+$92K
Total bought / sold$152K / $0

Reported trades

Filed Stock Type Shares Price Value Since
May 18SEC TLSITriSalus Life Sciences, Inc. Buy 60,000147,555 held (+69%) $2.53 $152K +60.5%
  • Buy

    Director Mats Wahlstrom bought $152K of TLSI at $2.53 — first open-market purchase in our records; raises the stake by 69%.